METASTATIC RENAL CELL CARCINOMA side effect
What is METASTATIC RENAL CELL CARCINOMA ?
Help Community - Describe Your Side Effect
Search FDA Side Effects
Ask Health Expert
METASTATIC RENAL CELL CARCINOMA and Recently Reported Side Effects
METASTATIC RENAL CELL CARCINOMA and 15 most Active Side Effect polls
METASTATIC RENAL CELL CARCINOMA and featured health surveys
Substances toxic to Health
Recent Hospital reviews
Comments about Side Effects
Hospital Quality reviews
Homecare Quality reviews
Drugs associated with METASTATIC RENAL CELL CARCINOMA
CYMBALTA INFLIXIMAB IRINOTECAN NEXAVAR REMICADE SORAFENIB SUTENTNexavar Side Effects Report #5741511-6
Physician from SLOVAKIA (Slovak Republic) reported NEXAVAR problem on Apr 07, 2008. Male patient, 51 years of age, was diagnosed with metastatic renal cell carcinoma and was treated with NEXAVAR. After drug was administered, patient experienced the following problems/side effects: metastatic renal cell carcinoma, . NEXAVAR dosage: TOTAL DAILY DOSE: 800 MG. Patient died on 02/26/2008.
Infliximab Side Effects Report #5350576-5
INFLIXIMAB problem was reported by a Health Professional from UNITED KINGDOM on May 29, 2007. Female patient, weighting 125.7 lb, was diagnosed with rheumatoid arthritis and was treated with INFLIXIMAB. After drug was administered, patient experienced the following problems/side effects: metastatic renal cell carcinoma, . INFLIXIMAB dosage: unknown. During the same period patient was treated with METHOTREXATE, ATENOLOL, COSARTAN. Patient died on 10/28/2005.
Nexavar Side Effects Report #5326200-4
Consumer or non-health professional from CHINA reported NEXAVAR problem on May 11, 2007. Male patient, 72 years of age, was treated with NEXAVAR. After drug was administered, patient experienced the following problems/side effects: metastatic renal cell carcinoma, myocardial infarction, . NEXAVAR dosage: TOTAL DAILY DOSE: 800 MG. Patient was hospitalized. Patient recovered.
Remicade Side Effects Report #5328587-5
REMICADE problem was reported by a Physician from UNITED KINGDOM on May 09, 2007. Female patient, weighting 141.1 lb, was diagnosed with ankylosing spondylitis and was treated with REMICADE. After drug was administered, patient experienced the following problems/side effects: metastatic renal cell carcinoma, . REMICADE dosage: unknown. During the same period patient was treated with ERGOTAMINE, PLZOTIFEN, METHOTREXATE, FOLIC ACID, FERROUS GLUCONATE, PANTOPRAZOLE, PIZOTIFEN, DIAZEPAM. Patient was hospitalized. Patient died on 01/08/2005.
Nexavar Side Effects Report #5282928-6
Physician from SWEDEN reported NEXAVAR problem on Mar 30, 2007. Male patient, 46 years of age, weighting 165.3 lb, was diagnosed with metastatic renal cell carcinoma, diarrhoea and was treated with NEXAVAR. After drug was administered, patient experienced the following problems/side effects: metastatic renal cell carcinoma, palmar-plantar erythrodysaesthesia syndrome, pruritus, . NEXAVAR dosage: TOTAL DAILY DOSE: 800 MG UNIT DOSE: 200 MG. During the same period patient was treated with IMODIUM. Patient recovered.
Sutent Side Effects Report #5669821-1
SUTENT problem was reported by a Consumer or non-health professional from UNITED STATES on Mar 05, 2008. Male patient, weighting 97.00 lb, was diagnosed with metastatic renal cell carcinoma and was treated with SUTENT. After drug was administered, patient experienced the following problems/side effects: disease progression, metastatic renal cell carcinoma, perirectal abscess, . SUTENT dosage: unknown. During the same period patient was treated with LEVAQUIN, VICODIN, MORPHINE, NYSTATIN, IMODIUM. Patient was hospitalized. Patient died on 10/11/2005.
Sorafenib Side Effects Report #5603752-8
Physician from GERMANY reported SORAFENIB problem on Jan 21, 2008. Male patient, 64 years of age, weighting 149.9 lb, was diagnosed with renal cell carcinoma, diarrhoea, gastritis and was treated with SORAFENIB. After drug was administered, patient experienced the following problems/side effects: dyspnoea, metastatic renal cell carcinoma, . SORAFENIB dosage: TOTAL DAILY DOSE: 800 MG UNIT DOSE: 400 MG. During the same period patient was treated with IMODIUM, PANTOZOL. Patient was hospitalized. Patient died on 01/31/2006.
Sutent Side Effects Report #5463461-5
SUTENT problem was reported by a Physician from GERMANY on Sept 11, 2007. Female patient, weighting 110.2 lb, was diagnosed with metastatic renal cell carcinoma and was treated with SUTENT. After drug was administered, patient experienced the following problems/side effects: cerebral infarction, metastatic renal cell carcinoma, neoplasm progression, . SUTENT dosage: DAILY DOSE:50MG. During the same period patient was treated with FUROSEMIDE, OMEPRAZOLE, DICLOFENAC. Patient died on 05/24/2007.
Nexavar Side Effects Report #5405596-9
Physician from UNITED STATES reported NEXAVAR problem on Aug 02, 2007. Male patient, 58 years of age, was treated with NEXAVAR. After drug was administered, patient experienced the following problems/side effects: intestinal perforation, metastatic renal cell carcinoma, multi-organ failure, peritonitis, . NEXAVAR dosage: TOTAL DAILY DOSE: 800 MG UNIT DOSE: 200 MG. Patient died on 01/15/2007.
Irinotecan Side Effects Report #5451164-2
IRINOTECAN problem was reported by a Physician from UNITED STATES on Oct 04, 2006. Female patient, 37 years of age, was diagnosed with metastatic renal cell carcinoma and was treated with IRINOTECAN. After drug was administered, patient experienced the following problems/side effects: disease progression, metastatic renal cell carcinoma, vomiting, . IRINOTECAN dosage: unknown. During the same period patient was treated with FLUOROURACIL, LEUCOVORIN CALCIUM, AVASTIN. Patient recovered.
Cymbalta Side Effects Report #5401706-8
Consumer or non-health professional from UNITED STATES reported CYMBALTA problem on July 18, 2007. Male patient, 65 years of age, was diagnosed with depression and was treated with CYMBALTA. After drug was administered, patient experienced the following problems/side effects: impaired driving ability, metastatic renal cell carcinoma, . CYMBALTA dosage: UNK MG, DAILY (1/D). Patient recovered.
Cymbalta Side Effects Report #5401706-8
CYMBALTA problem was reported by a Consumer or non-health professional from UNITED STATES on July 18, 2007. Male patient, 65 years of age, was diagnosed with depression and was treated with CYMBALTA. After drug was administered, patient experienced the following problems/side effects: impaired driving ability, metastatic renal cell carcinoma, . CYMBALTA dosage: UNK MG, DAILY (1/D). Patient recovered.
Sutent Side Effects Report #5775693-7
Consumer or non-health professional from UNITED STATES reported SUTENT problem on June 06, 2008. Male patient, weighting 97.00 lb, was diagnosed with metastatic renal cell carcinoma and was treated with SUTENT. After drug was administered, patient experienced the following problems/side effects: disease progression, metastatic renal cell carcinoma, perirectal abscess, . SUTENT dosage: unknown. During the same period patient was treated with LEVAQUIN, VICODIN, MORPHINE, NYSTATIN, IMODIUM. Patient was hospitalized. Patient died on 10/11/2005.
Sorafenib Side Effects Report #5780459-8
SORAFENIB problem was reported by a Physician from UNITED STATES on June 17, 2008. Male patient was diagnosed with renal cell carcinoma and was treated with SORAFENIB. After drug was administered, patient experienced the following problems/side effects: condition aggravated, metastatic renal cell carcinoma, . SORAFENIB dosage: TOTAL DAILY DOSE: 800 MG UNIT DOSE: 200 MG. During the same period patient was treated with SYNTHROID, ARANESP, NEXIUM. Patient was hospitalized. Patient died on 06/30/2006.
Sutent Side Effects Report #5713331-X
Consumer or non-health professional from UNITED STATES reported SUTENT problem on Apr 10, 2008. Female patient, weighting 134.9 lb, was diagnosed with metastatic renal cell carcinoma, bone pain, oedema peripheral, dyspnoea, chronic obstructive pulmonary disease and was treated with SUTENT. After drug was administered, patient experienced the following problems/side effects: disease progression, metastatic renal cell carcinoma, . SUTENT dosage: unknown. During the same period patient was treated with LORTAB, LASIX, OXYGEN, ZOMETA. Patient died on 02/06/2008.
Nexavar Side Effects Report #5355537-8
NEXAVAR problem was reported by a Physician from UNITED STATES on June 07, 2007. Male patient, 70 years of age, was diagnosed with metastatic renal cell carcinoma and was treated with NEXAVAR. After drug was administered, patient experienced the following problems/side effects: blood pressure increased, metastatic renal cell carcinoma, . NEXAVAR dosage: TOTAL DAILY DOSE: 800 MG UNIT DOSE: 200 MG. During the same period patient was treated with WARFARIN. Patient recovered.
Nexavar Side Effects Report #5301740-2
Consumer or non-health professional from UNITED STATES reported NEXAVAR problem on Apr 12, 2007. Male patient was treated with NEXAVAR. After drug was administered, patient experienced the following problems/side effects: blood pressure increased, metastatic renal cell carcinoma, . NEXAVAR dosage: TOTAL DAILY DOSE: 800 MG UNIT DOSE: 200 MG. During the same period patient was treated with WARFARIN. Patient recovered.
Sutent Side Effects Report #5266577-1
SUTENT problem was reported by a Health Professional from INDIA on Mar 05, 2007. Male patient, 44 years of age, was diagnosed with metastatic renal cell carcinoma and was treated with SUTENT. After drug was administered, patient experienced the following problems/side effects: disease progression, metastatic renal cell carcinoma, . SUTENT dosage: unknown. Patient died on 01/18/2007.
Nexavar Side Effects Report #5497372-6
Physician from ITALY reported NEXAVAR problem on Oct 17, 2007. Female patient, 79 years of age, was diagnosed with hypothyroidism, hypertension and was treated with NEXAVAR. After drug was administered, patient experienced the following problems/side effects: hemiplegia, ischaemic stroke, metastatic renal cell carcinoma, . NEXAVAR dosage: TOTAL DAILY DOSE: 800 MG UNIT DOSE: 200 MG. During the same period patient was treated with EUTIROX, CARDICOR, ASPIRIN. Patient was hospitalized. Patient recovered.
Nexavar Side Effects Report #5368624-5
NEXAVAR problem was reported by a Physician from UNITED STATES on June 19, 2007. Male patient, 70 years of age, weighting 194.0 lb, was diagnosed with metastatic renal cell carcinoma and was treated with NEXAVAR. After drug was administered, patient experienced the following problems/side effects: blood pressure increased, haemoptysis, metastatic renal cell carcinoma, . NEXAVAR dosage: TOTAL DAILY DOSE: 800 MG UNIT DOSE: 200 MG. During the same period patient was treated with WARFARIN. Patient recovered.
Sutent Side Effects Report #5335255-2
Physician from UNITED STATES reported SUTENT problem on May 14, 2007. Female patient, weighting 160.1 lb, was diagnosed with metastatic renal cell carcinoma and was treated with SUTENT. After drug was administered, patient experienced the following problems/side effects: ascites, disease progression, metastatic renal cell carcinoma, . SUTENT dosage: unknown. Patient was hospitalized. Patient died.
Sutent Side Effects Report #5299768-4
SUTENT problem was reported by a Physician from GERMANY on Apr 05, 2007. Female patient was diagnosed with metastatic renal cell carcinoma and was treated with SUTENT. After drug was administered, patient experienced the following problems/side effects: cardiomyopathy, disease progression, metastatic renal cell carcinoma, skin toxicity, ventricular dysfunction, . SUTENT dosage: DAILY DOSE:37.5MG. Patient was hospitalized. Patient recovered.
Sutent Side Effects Report #5264044-2
Physician from GERMANY reported SUTENT problem on Mar 01, 2007. Male patient was diagnosed with metastatic renal cell carcinoma and was treated with SUTENT. After drug was administered, patient experienced the following problems/side effects: malignant neoplasm progression, metastatic renal cell carcinoma, multi-organ failure, thrombocytopenia, . SUTENT dosage: DAILY DOSE:50MG. Patient died.